ACM Research, Inc. 8-K

What Happened
ACM Research, Inc. reported that its operating subsidiary, ACM Research (Shanghai), Inc. (ACM Shanghai), approved at its May 26, 2026 board meeting a proposal to offer H shares and seek listing on the Main Board of The Stock Exchange of Hong Kong Limited. ACM Shanghai is already listed on the Sci‑Tech Innovation Board of the Shanghai Stock Exchange. The H‑share listing plan remains subject to shareholder approval and required regulatory clearances and market conditions.

Key Details

• ACM Shanghai proposes to issue H shares representing no more than 7% of its total issued share capital upon completion (before any over‑allotment).
• An over‑allotment option of up to 15% of the initial H shares may be granted to overall coordinators.
• H shares would be ordinary H‑share class with par value RMB 1.00 per share.
• Net proceeds are intended for product development and R&D, global market expansion and service, working capital replenishment, and repayment of bank loans.
• Announcement posted to the Shanghai Stock Exchange on May 26, 2026; listing requires approvals (e.g., CSRC, HKEX, SFC).
• Resolution validity proposed for 24 months from shareholder approval, with automatic extension if regulatory approvals are obtained within that period until listing and any over‑allotment completion.

Why It Matters
This plan signals ACM’s intent to raise capital and expand its investor base via a Hong Kong listing for its Shanghai subsidiary. For investors, the move could provide additional funding for R&D and expansion (which the company cites as uses of proceeds) and may increase liquidity and visibility for ACM Shanghai, but completion depends on shareholder votes, regulatory approvals, market conditions and other uncertainties disclosed by the company.